EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Overview of attention for article published in Cancer Discovery, March 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 26 news outlets
blogs: 2 blogs
twitter: 7 X users

patent: 19 patents
f1000: 1 research highlight platform

Citations

dimensions_citation: 855 Dimensions

Readers on

mendeley: 514 Mendeley
citeulike: 1 CiteULike

Summary News Blogs X Patents Research highlights Dimensions citations

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 56,804 followers.

RT @CD_AACR: ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRA…

30 Mar 2021

Reply Repost Favourite

RT @CD_AACR: ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRA…

16 Mar 2021

Reply Repost Favourite

ICYMI— In celebration of the journal's 10th Anniversary, we're highlighting articles published in the past decade: Not All BRAF-Mutant Cancers Are Created Equal. #CDturns10 https://t.co/1k2yVi3bAH Read the article from the March 2012 issue: https://t.co

16 Mar 2021

Reply Repost Favourite

RT @ElizSMcKenna: Ryan Corcoran @MGHCancerCenter talking now at #AACR20 about his classic 2012 @CD_AACR paper about EGFR mediating resistan…

23 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.